Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Research Abstract |
We identified a gene of IBCAP with an incretin-like activity. We developed to assessment of IBCAP activity as an indexing of beta-cells proliferation, and we identified candidate of sequences activated peptides of IBCAP gene. Also, transgenic mice over-expressing IBCAP was demonstrated to have increased amount of pancreatic β-cells, whereas gene-knockouts of the factor resulted in a marked decrease of pancreatic islets. Our findings strongly suggested IBCAP as a major player in the control of the amount of pancreatic islets and β-cells. Our results demonstrated that we assume that IBCAP can be another potential therapeutic target for diabetes.
|